There are 13 papers on pepsinogen I in aging research: 1 trial and 9 observational studies in people, 1 in animals, 2 reviews.
13 papers study it9 more mention it6 findings
See all 22 papers on pepsinogen I
“serum levels of PG-I and the PG-I/-II ratio were significantly lower in the CAG group.”
- Human trial1
- Humans9
- Animals1
Interventions
1Netazepide
downin humans1−15%
1 study
Netazepide
downin humans1−15%
Netazepide decreases pepsinogen I in humans (-15%).
“Gastrin increased by 90% in response to GRA as early as 7 d (p-value for treatment.0008), and group I pepsinogens decreased by 15% as early as 7 d (p-value for treatment.0002).”
Human trial90 dfemalesn = 99
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Netazepide decreases pepsinogen I in humans (-15% (p = .0002)).
“group I pepsinogens decreased by 15% as early as 7 d (p-value: .0002)”
Human trial100 mg daily90 dfemalesn = 99
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Associations
4Atrophic gastritis
downin humans1
1 study
Atrophic gastritis
downin humans1
Atrophic gastritis is associated with pepsinogen I in MCCG-detected CAG.
“serum levels of PG-I and the PG-I/-II ratio were significantly lower in the CAG group.”
Humansin MCCG-detected CAG
Frontiers in medicine
Gastric precancerous lesions
downin humans1
1 study
Gastric precancerous lesions
downin humans1
Pepsinogen I is linked with a lower risk of gastric precancerous lesions in H. pylori-positive outpatients.
“whereas higher PG I, higher PGR, and frequent whole-grain intake were protective.”
Humansin H. pylori-positive outpatientsn = 82
Medicine
Age
upin humans1
1 study
Age
upin humans1
Age is associated with pepsinogen I in humans (healthy individuals in northern China) (25.16% increase; median 39.75 to 49.75 μg/L from age 20 to 60 years, then plateau through age 80 years).
“PG I increased from a median of 39.75 μg/L at age 20 years to 49.75 μg/L at age 60 years, a 25.16% increase”
Humanshealthy individuals in northern Chinaserumn = 708
World journal of gastroenterology
Hp-IgG
upin humans1
1 study
Hp-IgG
upin humans1
Hp-IgG is associated with pepsinogen I in humans (P < 0.001).
“Hp-IgG level positively correlated with PGI, PGII and G-17 (P < 0.001, P < 0.001, P = 0.006)”
Humansn = 395
World journal of gastroenterology